As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
On Monday, Medley Capital Corporation (MCC)'s Director, Seth Taube, made a $499,345 purchase of MCC, buying 66,585 shares at a cost of $7.50 each. So far Taube is in the green, up about 2.4% on their purchase based on today's trading high of $7.68. Medley Capital Corporation is trading up about 2% on the day Tuesday. Before this latest buy, Taube purchased MCC at 17 other times during the past year, for a total investment of $17.45M at an average of $7.38 per share.
And on Thursday, Director John Poyhonen purchased $122,000 worth of Heron Therapeutics (NASDAQ:HRTX), purchasing 10,000 shares at a cost of $12.20 each. This buy marks the first one filed by Poyhonen in the past year. Heron Therapeutics is trading off about 1.2% on the day Tuesday. So far Poyhonen is in the green, up about 6.1% on their purchase based on today's trading high of $12.95.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.